论文部分内容阅读
目的观察比较银杏达莫注射液与脉络宁治疗急性脑梗死的临床效果。方法选取医院收治的急性脑梗死患者110例,根据治疗方案分为观察组和对照组,每组55例。对照组采用脉络宁注射液治疗,观察组采用银杏达莫注射液治疗。治疗结束后对2组患者神经功能缺损程度评分、血流动力学指标、血清C反应蛋白、临床疗效进行比较。结果观察组总有效率为90.9%,高于对照组的69.1%(P<0.01)。治疗后2组NIHSS评分均较治疗前下降,且观察组低于对照组(P<0.01)。治疗后观察组血流动力学指标和血清C反应蛋白较对照组降低(P<0.05)。2组均未发生药物不良反应。结论银杏达莫注射液治疗急性脑梗死临床疗效更好,且安全性较高。
Objective To compare the clinical effects of Yinxingdamo injection with Mailuoning in treating acute cerebral infarction. Methods A total of 110 patients with acute cerebral infarction admitted to hospital were selected and divided into observation group and control group according to the treatment plan, with 55 cases in each group. The control group was treated with Mailuoning injection, and the observation group was treated with Yinxingdamo injection. After treatment, the scores of neurological deficit, hemodynamics, serum C-reactive protein and clinical efficacy were compared between the two groups. Results The total effective rate in observation group was 90.9%, which was higher than 69.1% in control group (P <0.01). NIHSS scores of two groups after treatment decreased compared with before treatment, and the observation group was lower than the control group (P <0.01). After treatment, the hemodynamics and serum C-reactive protein in observation group were lower than those in control group (P <0.05). No adverse drug reactions occurred in both groups. Conclusion Yin Xing Damo injection for the treatment of acute cerebral infarction better clinical efficacy and safety.